Itameline (INN; developmental code name RU-47213) is a non-selective muscarinic acetylcholine receptor agonist nootropic drug which was under development for the treatment of Alzheimer's disease and memory disorders but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.